Additional file 1: of Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR)

Tenorio-Jiménez, Carmen; Martínez-Ramírez, María; Tercero-Lozano, Mercedes; Arraiza-Irigoyen, Carmen; Del Castillo-Codes, Isabel; Olza, Josune; Plaza-Díaz, Julio; Fontana, Luis; Migueles, Jairo; Olivares, Mónica; Gil, Ángel; Gomez-Llorente, Carolina

doi:10.6084/m9.figshare.7362521.v1

12906_2018_2371_MOESM1_ESM.doc (120.5 kB)

Additional file 1: of Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR)

journal contribution

posted on 2018-11-20, 05:00 authored by Carmen Tenorio-Jiménez, María Martínez-Ramírez, Mercedes Tercero-Lozano, Carmen Arraiza-Irigoyen, Isabel Del Castillo-Codes, Josune Olza, Julio Plaza-Díaz, Luis Fontana, Jairo Migueles, Mónica Olivares, Ángel Gil, Carolina Gomez-Llorente

SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documents. (DOC 120 kb)

Funding

Biosearch life

History

Usage metrics

Keywords

Human adults Insulin resistance syndrome Lactobacillus reuteri V3401 Non-alcoholic fatty liver disease Obesity Probiotics

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR)

Funding

Biosearch life

History

Usage metrics

Categories

Keywords

Licence

Exports